Previous close | 86.43 |
Open | 86.43 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's range | 85.13 - 87.21 |
52-week range | 60.57 - 96.12 |
Volume | |
Avg. volume | 4,057,317 |
Market cap | 51.793B |
Beta (5Y monthly) | 1.07 |
PE ratio (TTM) | 37.05 |
EPS (TTM) | 2.32 |
Earnings date | 24 July 2024 - 29 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 94.86 |
Explore how Edwards Lifesciences' (EW) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
Edwards Lifesciences ( NYSE:EW ) First Quarter 2024 Results Key Financial Results Revenue: US$1.60b (up 9.5% from 1Q...